Checchi Capital Advisers, LLC Intellia Therapeutics, Inc. Transaction History

Checchi Capital Advisers, LLC

  • $1.78 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$132.37 - $176.78 $248,590 - $331,992
-1,878 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$60.88 - $161.91 $38,780 - $103,136
-637 Reduced 25.33%
1,878 $304,000
Q1 2021

May 10, 2021
BUY
$46.59 - $83.68 $117,173 - $210,455
2,515 New
2,515 $202,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $922M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email